AgomAb Therapeutics NV

FY: Dec 31 2025

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Notice of Effectiveness

Registration statement for securities of certain foreign private issuers (amendment)

Registration statement for securities of certain foreign private issuers

Garcia Marino

Garcia Marino

Patel Naimish

Patel Naimish

Cormorant Asset Management, LP

Redmile Group, LLC

Sanofi

Pontifax Management 4 G.P. (2015) Ltd.

Kemula Pierre Thadee Victor

Lefever Ellen

Borderias Andrea Saez

van der Horst Paul Henryk

Verduyn-van Weegen Felice Isabel

Wiesel Philippe Constantin

Bond Colin Michael

Epstein David R

Hammer Ohad

Jahreis Angelika Martha

Knotnerus Tim Jasper

FMR LLC

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission)